Related Articles
Antibiotic Resistance Surveillance Systems: A Review.
J Glob Antimicrob Resist. 2020 Nov 08;:
Authors: Diallo OO, Baron SA, Abat C, Colson P, Chaudet H, Rolain JM
Abstract
OBJECTIVE:…
Related Articles
Distinct Effectiveness of Oritavancin against Tolerance-Induced Staphylococcus aureus.
Antibiotics (Basel). 2020 Nov 08;9(11):
Authors: Berti AD, Harven LT, Bingley V
Abstract
Within…
Related Articles
Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review.
Paediatr Drugs. 2020 Nov 10;:
Authors: Willems J, Hermans E, Schelstraete P, Depuydt P, De Cock P
…
Related Articles
Decision Tools and Studies to Improve the Diagnosis of Urinary Tract Infection in Nursing Home Residents: A Narrative Review.
Drugs Aging. 2020 Nov 11;:
Authors: Mylotte JM
Abstract
…
Related Articles
Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review.
Rev Soc Bras Med Trop. 2020;53:e20200413
Authors: Zequinão T, Telles JP, Gasparetto J, Tuon FF
Abstract
…
SUMMARYThe limited armamentarium against drug-resistant Gram-negative bacilli has led to the development of several novel β-lactam-β-lactamase inhibitor combinations (BLBLIs). In this review, we summarize their spectrum of in vitro activities, mechanisms of resistance, and pharmacokinetic-pharmacodynamic (PK-PD) characteristics. A summary of available clinical data is provided per drug. Four approved BLBLIs are discussed in detail. All are options for treating multidrug-resistant (MDR)…
